Literature DB >> 3824433

Enantioselective analysis of chloroquine and desethylchloroquine after oral administration of racemic chloroquine.

D Ofori-Adjei, O Ericsson, B Lindström, J Hermansson, K Adjepon-Yamoah, F Sjöqvist.   

Abstract

An enantioselective high-performance liquid chromatographic method for chloroquine and desethylchloroquine was developed using a chiral alpha 1-acid glycoprotein column. This method was used to determine concentrations of chloroquine and desethylchloroquine enantiomers in plasma and urine from volunteers given single oral doses of racemic chloroquine. The disposition of the enantiomers was different. The renal clearance of the chloroquine enantiomers was indicative of stereoselective renal secretion of the drug, and evidence for stereoselective metabolism also was found.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3824433     DOI: 10.1097/00007691-198612000-00014

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  11 in total

Review 1.  Stereoselectivity in clinical pharmacokinetics and drug development.

Authors:  D B Campbell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Apr-Jun       Impact factor: 2.441

Review 2.  Chirality. Clinical pharmacokinetic and pharmacodynamic considerations.

Authors:  E J Lee; K M Williams
Journal:  Clin Pharmacokinet       Date:  1990-05       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

4.  Interpretation of chloroquine pharmacokinetic data.

Authors:  A McLachlan; S Tett; R Day; D Cutler
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 5.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of drugs used in juvenile arthritis.

Authors:  K J Skeith; F Jamali
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

7.  Stereoselective pharmacokinetic properties of chloroquine and de-ethyl-chloroquine in humans.

Authors:  P Augustijns; N Verbeke
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

Review 8.  Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.

Authors:  Dion R Brocks; Reza Mehvar
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Disposition of the enantiomers of hydroxychloroquine in patients with rheumatoid arthritis following multiple doses of the racemate.

Authors:  A J McLachlan; S E Tett; D J Cutler; R O Day
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of slow-acting antirheumatic drugs.

Authors:  S E Tett
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.